Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new framework that could influence the future regulation and adoption of medical AI.
Introduction:
As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new framework that could influence the future regulation and adoption of medical AI.
Why was this article needed?:
Current regulatory pathways primarily treat clinical AI systems as medical devices. However, this approach may not be appropriate for open-source AI assistants that are transparent, peer-reviewed, and used by physicians as decision-support tools. The author argues that an alternative regulatory model is needed.
What did the article show?:
The author introduces the concept of a Medical Artificial Intelligence Assistant (MAIA)—an open-weight generative AI model integrated with a patient's health records through a secure vector database and used by physicians via an open-source interface. If the AI architecture, retrieval methods, and clinical validation are published in peer-reviewed journals, MAIA should be regarded as a published clinical methodology rather than a commercial medical device. Physicians using such validated systems are applying evidence from the medical literature, similar to adopting a published clinical guideline or risk score.
Clinical Impact:
This framework could encourage greater transparency, peer review, independent validation, and open scientific collaboration while reducing dependence on proprietary "black-box" AI systems. It also highlights the importance of physician oversight, reproducibility, and evidence-based implementation as AI becomes part of routine clinical practice.
Take-Home Message:
This perspective challenges the traditional view that every clinical AI tool should be regulated as a medical device. Instead, it proposes that transparent, peer-reviewed, open-source AI assistants may evolve into evidence-based clinical methodologies, potentially reshaping AI regulation, physician adoption, and the future standard of care.
Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...
Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...
Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...
Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....
Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...
Introduction: Large language models (LLMs), exemplified by ChatGPT and similar artificial intelligence platforms, are rapidly reshaping healthcare delivery, medical education, and scientific research. In gastroenterology, these technologies have the potential to support clinical decision-making, streamline...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.